OVERVIEW | NEWS | MULTIMEDIA | RESEARCH |
SSL International plc Company Summary |
|
|
COMPANY DATA |
|||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Headquarters | 35 New Bridge Street |
| London | ||
| EC4V 6BW | ||
![]() |
Telephone | +44 20 7367 5760 |
![]() |
Fax | +44 20 7367 5790 |
![]() |
Principal Sector | Health & Pharm General |
![]() |
Principal Industry | Healthcare |
![]() |
Homepage | www.ssl-international.com |
Key Developments: SSL International plc
![]() |
Starpharma Holdings Limited (ASX:SPL) Raises Additional Capital Up To A$4.6 Million Via Institutional Placement APR 7, 2009 09:42 - Article Views: 2,505 Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) today announced a successful capital raising of at least A$4.3 million and up to A$4.6 million, through a private placement to existing and new institutional and sophisticated investors. | |
![]() |
Starpharma Holdings Limited (ASX:SPL) Announce Key VivaGel(R) Patent Approved in Japan OCT 30, 2008 09:28 - Article Views: 1,877 Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced that one of its key patents relating to the use of dendrimers to protect against sexually transmitted infections has been approved in Japan. | |
5,787 COMPANY PROFILE VIEWS |
||||
|
|
|
Site Search
| ENGLISH All Languages |
Companies in the News
ABN Newswire on iPhone/iPad
|
| Download from Apple |
Mobile Video TV
|
||
|
||





